Increased dietary folic acid intake may lead to adverse health effects, including inflammation and neurotoxicity, ...

Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.

A retrospective study showed that either folate receptor alpha or B7-H4 was expressed in more than 80% of endometrial cancers ...

AstraZeneca has been busy in recent years pumping up its oncology pipeline via a shopping list of assets and companies. | ...

Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative ...

Role of Folate Receptor Alpha Testing Mirvetuximab soravtansine, an antibody-drug conjugate targeting FRα, represents the newest approved therapy in ovarian cancer. Testing considerations include ...

Mirvetuximab soravtansine shows no significant HRQoL detriments despite TEOEs in FRα+ platinum-resistant ovarian cancer patients. The phase 3 MIRASOL trial confirms improved progression-free and ...

Epsilogen has acquired antibody developer TigaTx in a deal that collates work from the companies’ alternative antibody ...

data from the pivotal SORAYA trial – means adult patients with folate receptor alpha (FRα)-positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer ...